A scalable model for Parkinson's disease genetic research in underrepresented populations: lessons from Kyrgyzstan

BackgroundScalable models for Parkinsons disease (PD) genetics in underrepresented populations are needed, as most studies have focused on individuals of European-ancestry, limiting generalisability across ancestral and environmental contexts. Kyrgyzstan has been largely absent from global PD research. Using Kyrgyzstan as a case study, we aimed to develop and evaluate a scalable PD genetics model integrating research and local capacity building. MethodsWe implemented a stepwise capacity-building framework within a multi-site prospective PD genetics cohort that included participants with PD and controls, with longitudinal follow-up. The framework integrated community engagement, workforce development, specialist clinical services, data governance, clinical phenotyping, biobanking, and genetic data generation. Participants were recruited through a university-affiliated movement disorders clinic and mobile outreach clinics, using a secure electronic data-capture system and Global Parkinsons Genetics Program (GP2)-aligned standards. Feasibility endpoints included recruitment, participation, assessment completeness, and genetic quality-control metrics. FindingsWithin 20 months, specialist clinical services and a PD registry with biobanking and secure data infrastructure were established, and 1240 participants were enrolled, representing multiple Central Asian ethnicities, including Kyrgyz, Uzbek, Uyghur, Tatar, Kalmyk, and Dungan, and the countrys rural- urban distribution. High participation coincided with community engagement and recruitment through mobile clinics and community outreach. InterpretationEmbedding capacity building within active research enabled rapid development of neurogenetic and specialist clinical infrastructure in a resource-limited setting. This programme provides a potentially transferable model for equitable inclusion of underrepresented populations in PD genetics and related neurogenetic research in low- and middle-income countries. FundingThis project was supported by the Global Parkinsons Genetics Program (GP2; https://gp2.org). GP2 is funded by the Aligning Science Across Parkinsons (ASAP) initiative and implemented by The Michael J. Fox Foundation for Parkinsons Research (MJFF) Research in contextO_ST_ABSEvidence before this studyC_ST_ABSWe searched PubMed/MEDLINE and Scopus from 1995 to July 2026 for articles and reviews using combinations of terms related to Parkinsons disease (PD), genetics, genomics, underrepresented populations (URP), ancestry, diversity, implementation, research infrastructure, capacity building, governance, and consortium development. Additional relevant publications were identified by reviewing the reference lists of pertinent articles. Eligible papers were categorized by study design, focus on implementation, implementation domains, and relevance to this research (Supplementary Table S1). Most available work comprises genome wide association studies, genetic discovery research, and reviews that address the lack of diversity in PD genetics. Several studies documented persistent ancestry disparities and underrepresentation of URP and called for broader inclusion, while regional reviews summarised evidence from Africa, Latin America, and other underserved regions. Few publications examined implementation issues such as international partnerships, governance, workforce training, consortium structures, or data sharing systems. Initiatives including the Global Parkinsons Genetics Program (GP2), the International Parkinson Disease Genomics Consortium (IPDGC), the African and Arabian Parkinsons Disease Genetics Consortium (AA PD GC), and the Michael J. Fox Foundation Global Genetic Parkinsons Disease Project demonstrated that coordinated consortia can be built successfully. However, there is little published guidance on how to design and run integrated PD genomic programmes for URP, particularly in low resource settings or in Central Asia. Added value of this studyThis study describes the prospective development and assessment of an integrated genomic programme for PD embedded within routine neurological care in Kyrgyzstan, a Central Asian population previously unrepresented in PD genetics research. The project established a nationwide cohort and biobank, together with governance frameworks, workforce training, standardised clinical phenotyping, biospecimen collection, data management, community engagement, and routes for international data sharing. By analysing data collected during the setup phase, we identify operational obstacles and propose practical solutions to support sustainable integration of genomic research into clinical practice. Rather than focusing only on genetic discoveries, we outline an implementation model that could be adapted for similar URP. Implications of all the available evidenceCurrent literature highlights the scientific importance of increasing ancestral diversity in PD genetics but offers limited direction on how to build and sustain such research in underrepresented regions. Our findings suggest that successful implementation depends on coordinated development of clinical services, governance, workforce capacity, biobanking, data infrastructure, community engagement, and international collaboration alongside genomic research. The model presented here may help guide future efforts to improve equitable participation in PD genetic studies and to strengthen research capacity in other resource-limited and underserved settings.